KALARIS THERAPEUTICS, INC. Preferred Stock, Dividend Rate, Percentage
KALARIS THERAPEUTICS, INC. (KLRS) reported Preferred Stock, Dividend Rate, Percentage of 8.00% for the 12-month period ending 2020-12-31, per its 10-K filed 2021-02-12.
Discontinued › Notes › Preferred Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:PreferredStockDividendRatePercentage · last filed 2021-02-12
- KALARIS THERAPEUTICS, INC. preferred stock, dividend rate, percentage for fiscal 2020 was 8.00%.
| Period end | Preferred Stock, Dividend Rate, Percentage 6 month | Preferred Stock, Dividend Rate, Percentage 9 month | Preferred Stock, Dividend Rate, Percentage 12 month |
|---|---|---|---|
| 2020-12-31 | 8.00% 10-K · filed 2021-02-12 | ||
| 2020-09-30 | 8.00% 10-Q · filed 2020-11-10 | ||
| 2020-06-30 | 8.00% 10-Q · filed 2020-09-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |